132312-25-5 Usage
Description
(4-dimethylaminomethyl-phenyl)-acetonitrile, with the molecular formula C11H14N2, is a white to pale yellow solid that exhibits a strong odor. This chemical compound features a phenyl group and a nitrile functional group, which contribute to its versatility in chemical reactions and processes. It is a building block in the synthesis of pharmaceuticals and other organic compounds, making it a valuable component in the development of new drugs and materials.
Uses
Used in Pharmaceutical Industry:
(4-dimethylaminomethyl-phenyl)-acetonitrile is used as a key intermediate in the synthesis of various pharmaceuticals. Its presence of a phenyl group and a nitrile functional group allows for a wide range of chemical reactions, enabling the creation of diverse drug molecules with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, (4-dimethylaminomethyl-phenyl)-acetonitrile serves as a valuable building block for the development of new organic compounds. Its functional groups facilitate various chemical reactions, making it a useful component in the synthesis of a broad spectrum of organic molecules for different applications.
It is crucial to handle (4-dimethylaminomethyl-phenyl)-acetonitrile with care, as it is potentially hazardous. Only trained professionals should work with this compound in a controlled laboratory setting to ensure safety and proper use.
Check Digit Verification of cas no
The CAS Registry Mumber 132312-25-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,3,1 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 132312-25:
(8*1)+(7*3)+(6*2)+(5*3)+(4*1)+(3*2)+(2*2)+(1*5)=75
75 % 10 = 5
So 132312-25-5 is a valid CAS Registry Number.
132312-25-5Relevant articles and documents
Beta-ketoamide compounds with MCH antagonistic activity
-
Page/Page column 32, (2008/06/13)
Compounds of formula I wherein the groups and residues A, B, b, X, Y, Z, R1, R2, R3, R5a and R5b have the meanings given in claim 1. The invention further relates to pharmaceutical compositions containing at least one amide according to the invention. As a result of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia, and diabetes.
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
-
Page/Page column 41, (2010/02/09)
The present invention relates to carboxamide compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1, R2, R3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
